Noguchi Katsuo, Kuwada Eri, Goto Shigenori, Egawa Kohji
Institute of Molecular Immunology, Medinet, Tamagawadai, Setagaya-ku, Tokyo 158-0096 and 2Seta Clinic, 4-20-18 Seta, Setagayaku, Tokyo 158-0095, Japan.
Anticancer Res. 2004 Sep-Oct;24(5C):3379-86.
We previously reported that the Q5 gene product (Q5 antigen) was expressed on the surface of various tumor cells derived from H-2k (Qa-2-) mice. The Q5 antigen has tumor-protective antigenicity in the syngeneic mice.
Transcripts of the Qa region genes were analyzed by the RT-PCR method. Cell fractionation was performed with the MACS method and the phenotypes were estimated by flow cytometry analysis.
Transcripts of Q5 were produced by all tumor cell lines. The Q5 transcription was detected only in thymocytes and PBMCs of H-2k (AKR and C3H/He) mice. The phenotype of the PBMCs in which Q5 transcription takes place seems to be, at least partly, CD3-48 cells that might be related to CD3-4-8- spontaneous thymoma cells derived from an H-2k mouse.
The expression of Q5 in tumor cells in general is a result of a change of transcriptional regulation associated with malignant transformation.
我们之前报道过,Q5基因产物(Q5抗原)在源自H-2k(Qa-2-)小鼠的各种肿瘤细胞表面表达。Q5抗原在同基因小鼠中具有肿瘤保护抗原性。
采用RT-PCR方法分析Qa区域基因的转录本。用MACS方法进行细胞分级分离,通过流式细胞术分析评估细胞表型。
所有肿瘤细胞系均产生Q5转录本。仅在H-2k(AKR和C3H/He)小鼠的胸腺细胞和外周血单核细胞中检测到Q5转录。发生Q5转录的外周血单核细胞的表型似乎至少部分是CD3-48细胞,这可能与源自H-2k小鼠的CD3-4-8-自发性胸腺瘤细胞有关。
一般来说,肿瘤细胞中Q5的表达是与恶性转化相关的转录调控变化的结果。